Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Non Operating Income (2012 - 2026)

Precigen (PGEN) posted quarterly Non Operating Income of -$1.9 million for Q1 2026, up 93.87% year-over-year from -$998100.6 in Q1 2025, and down 5.33% quarter-over-quarter from -$1.8 million in Q4 2025.

Analysis

Precigen (PGEN) Non Operating Income (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Non Operating Income for 15 consecutive years, with -$1.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non Operating Income rose 93.87% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$110.5 million (down 338.55% YoY), while the FY2025 annual figure was -$140.1 million, down 2101.6% from the prior year.
  • Non Operating Income eased to -$1.9 million in Q1 2026 per PGEN's latest filing, from -$1.8 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $8.7 million in Q4 2024 and bottomed at -$111.9 million in Q3 2025.
  • Historically, Non Operating Income has averaged -$8.0 million across 5 years, with a median of -$372000.0 in 2022.
  • On a YoY basis, Non Operating Income climbed as much as 1323.61% in 2025 and fell as far as 5007.78% in 2025.
  • Precigen's Non Operating Income stood at -$372000.0 in 2022, then jumped by 324.73% to $836000.0 in 2023, then jumped by 940.91% to $8.7 million in 2024, then plunged by 121.11% to -$1.8 million in 2025, then retreated by 5.33% to -$1.9 million in 2026.
  • Business Quant data shows PGEN's Non Operating Income at -$1.9 million in Q1 2026, -$1.8 million in Q4 2025, and -$111.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -139.24 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -51.63 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn -2.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.57 Mn
Mar 31, 2026 -1.94 Mn
Dec 31, 2025 -1.84 Mn
Sep 30, 2025 -111.86 Mn
Jun 30, 2025 5.13 Mn
Mar 31, 2025 -31.56 Mn
Dec 31, 2024 8.70 Mn
Sep 30, 2024 -2.70 Mn
Jun 30, 2024 360,000.00
Mar 31, 2024 643,000.00
Dec 31, 2023 836,000.00
Sep 30, 2023 1.14 Mn
Jun 30, 2023 736,000.00
Mar 31, 2023 689,000.00
Dec 31, 2022 -372,000.00
Sep 30, 2022 -942,000.00
Jun 30, 2022 -1.99 Mn
Mar 31, 2022 -1.80 Mn
Dec 31, 2021 -4.81 Mn
Sep 30, 2021 -4.85 Mn